Natera Corp - רווח נקי למניה בארבעת הרבעונים האחרונים NTRA

Natera Inc (NTRA) - לוגו תאגידי

Effective management at Natera, Inc. (NTRA) has ensured the transition to a profitable genomic model. The history of percentage changes in EPS YoY (ttm) demonstrates profit dynamics, where the value of 50.20 characterizes this level. Proprietary cancer diagnostics allow the company to exercise pricing power regarding insurance payouts. The process concludes with the rapid delivery of biomaterials to laboratories via optimized courier routes.

Natera Inc (NTRA): רווח למניה בשנים עשר החודשים האחרונים מ-11.02.2024 עד 17.11.2026

Natera Medical - פילוחים אנליטיים ומדדי מפתח (NTRA)

- מחיר מניה ומחיר יעד קונצנזוס:
הערכת שווי פונדמנטלית:Natera (NTRA)
מוצרים מוגמרים של Natera Corp

Natera, Inc. (NTRA) is actively scaling its staff of geneticists and bioinformaticians to expand its leadership in diagnostics. Hiring dynamics and operating expenses directly impact net income, which this indicator digitizes. The metric measures the rolling annual growth rate of earnings per share, revealing the business's ability to offset inflation. Analyzing the annual change in EPS (TTM) helps avoid overpaying for the asset when buying at local peaks.